Geerke Duijzer1, Annemien Haveman-Nies2, Sophia C Jansen3, Josien ter Beek3, Gerrit J Hiddink4, Edith J M Feskens5. 1. Wageningen University, Division of Human Nutrition, Academic Collaborative Centre AGORA, Wageningen, The Netherlands. Electronic address: geerke.duijzer@wur.nl. 2. Wageningen University, Division of Human Nutrition, Academic Collaborative Centre AGORA, Wageningen, The Netherlands; GGD Noord- en Oost-Gelderland (Community Health Service), Apeldoorn, The Netherlands. 3. GGD Noord- en Oost-Gelderland (Community Health Service), Apeldoorn, The Netherlands. 4. Wageningen University, Strategic Communication, Sub-department Communication, Philosophy and Technology: Centre for Integrative Development, Social Sciences, Wageningen, The Netherlands. 5. Wageningen University, Division of Human Nutrition, Academic Collaborative Centre AGORA, Wageningen, The Netherlands.
Abstract
OBJECTIVE: Pilot-testing of the adapted Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM) and to determine its feasibility and likelihood of achieving desired impact. METHODS: Pilot intervention study (a 10-month combined lifestyle intervention) using a one group pre-test post-test design with on-going process measures (i.e. reach, acceptability, implementation integrity, and applicability) and several health outcomes (e.g. body weight). RESULTS: In total, 31 subjects participated in the SLIMMER (SLIM iMplementation Experience Region Noord- en Oost-Gelderland) intervention. Participant weight loss was -3.5 kg (p=0.005). Both participants and health care professionals (i.e. practice nurses, dieticians, and physiotherapists) were satisfied with the intervention. The intervention was implemented as planned and appeared to be suitable for application in practice. Refinements have been identified and will be made prior to further implementation and evaluation. CONCLUSION: Implementation of the SLIMMER intervention is feasible in a Dutch real-life setting and it is likely to achieve desired impact. Practising and optimising the intervention creates local support for SLIMMER among stakeholders. PRACTICE IMPLICATIONS: Performing a pilot study on the basis of a structured approach is a meaningful step in the process of optimising the feasibility and potential impact of an evidence-based intervention in a real-life setting.
OBJECTIVE: Pilot-testing of the adapted Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM) and to determine its feasibility and likelihood of achieving desired impact. METHODS: Pilot intervention study (a 10-month combined lifestyle intervention) using a one group pre-test post-test design with on-going process measures (i.e. reach, acceptability, implementation integrity, and applicability) and several health outcomes (e.g. body weight). RESULTS: In total, 31 subjects participated in the SLIMMER (SLIM iMplementation Experience Region Noord- en Oost-Gelderland) intervention. Participantweight loss was -3.5 kg (p=0.005). Both participants and health care professionals (i.e. practice nurses, dieticians, and physiotherapists) were satisfied with the intervention. The intervention was implemented as planned and appeared to be suitable for application in practice. Refinements have been identified and will be made prior to further implementation and evaluation. CONCLUSION: Implementation of the SLIMMER intervention is feasible in a Dutch real-life setting and it is likely to achieve desired impact. Practising and optimising the intervention creates local support for SLIMMER among stakeholders. PRACTICE IMPLICATIONS: Performing a pilot study on the basis of a structured approach is a meaningful step in the process of optimising the feasibility and potential impact of an evidence-based intervention in a real-life setting.
Authors: Ellen B M Elsman; Joanne N Leerlooijer; Josien Ter Beek; Geerke Duijzer; Sophia C Jansen; Gerrit J Hiddink; Edith J M Feskens; Annemien Haveman-Nies Journal: BMC Public Health Date: 2014-10-27 Impact factor: 3.295
Authors: G Duijzer; A Haveman-Nies; S C Jansen; J Ter Beek; R van Bruggen; M G J Willink; G J Hiddink; E J M Feskens Journal: Nutr Diabetes Date: 2017-05-08 Impact factor: 5.097